Skip to main content
Premium Trial:

Request an Annual Quote

NIH Gives Illumina $9M to Help Study Common Diseases

NEW YORK, Oct. 1 - The US National Institutes of Health has given Illumina a $9 million award to perform "large-scale genotyping" studies and help the agency study a variety of "common" disorders, the company said yesterday.


Illumina said it will dispatch its Scientific Operations and Oligator oligo teams, which will apply the company's BeadArray technology to the NIH studies. The NIH hopes to get insight into diseases ranging from cancer to Alzheimer's.


Click here for more information.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.